Chembio enters wider US market with CLIA waiver for HIV barrel test
This article was originally published in Clinica
Executive Summary
Granting the company wider access to the US market, Chembio Diagnostics has received CLIA waiver status for its rapid HIV Barrel test. Potentially an additional 189,000 testing sites across the US can now use the test.